TG Therapeutics Raises FY2026 Sales Guidance from $925.000M to $950.000M vs $942.370M Est
TG Therapeutics (NASDAQ: TGTX ) raises FY2026 sales outlook from $925.000 million to $950.000 million vs $942.370 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.